Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001181431-08-016023
Filing Date
2008-03-04
Accepted
2008-03-04 17:45:17
Documents
1
Period of Report
2008-03-03

Document Format Files

Seq Description Document Type Size
1 FORM 4 rrd198312.html 4  
1 FORM 4 rrd198312.xml 4 3607
  Complete submission text file 0001181431-08-016023.txt   5614
Mailing Address ONE AMGEN CENTER DRIVE MAIL STOP 27-3-C THOUSAND OAKS CA 91320-1799
Business Address ONE AMGEN CENTER DRIVE THOUSAND OAKS CA 91320-1799 805-447-1000
AMGEN INC (Issuer) CIK: 0000318154 (see all company filings)

EIN.: 953540776 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address ONE AMGEN CENTER DRIVE THOUSAND OAKS CA 91320-1799
Business Address ONE AMGEN CENTER DRIVE THOUSAND OAKS CA 91320-1799 8054471000
Michael A Kelly (Reporting) CIK: 0001335311 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-12477 | Film No.: 08665185